New cases of illness associated with injectable pain medication from the New England Compounding Center continue to appear, more than two months after physicians pulled the steroid from their shelves over reports of contamination.
Although the period of highest risk for death and stroke has long passed, some patients who received doses of methylprednisolone acetate, produced by NECC prior to the product's recall on Sept. 26., are developing localized fungal infections around the site where they were injected, according to state health officials in Tennessee. That state has one of the highest case counts in the nation.
